Status:
COMPLETED
Injectable Filler for Facial Soft Tissue Augmentation
Lead Sponsor:
Panaxia Ltd
Conditions:
Wrinkles
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the safety and performance of Hydroxytite in all subjects who have received sub dermal or deep dermal injections.
Eligibility Criteria
Inclusion
- Patient is over 18 years of age
- Patient received Hydroxytite injection(s).
Exclusion
- • Patient declines to participate in the study
Key Trial Info
Start Date :
December 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT02218788
Start Date
December 1 2013
End Date
August 1 2018
Last Update
August 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.